Background & objectives: Uterovaginal prolapse is the protrusion of a pelvic organ beyond its normal anatomical confines. It is a silent disorder with a huge impact on women’s quality of life. It is symptomatic in 10% of women which usually require surgery; however milder stages of prolapse are commonly asymptomatic and surgical intervention is not indicated. The aim of the study was to evaluate the effectiveness of Mocharas (Bombax malabaricum) and Habbulaas (Myrtus communis) in first and second degree uterovaginal prolapse.

Methods: A randomized open clinical trial was carried out at the Institute’s Hospital, Bangalore. Patients (n=40) with 1^st & 2^nd degree uterovaginal prolapse in the age group of 30-60 years were randomly allocated in two equal groups (A & B). In Group A, 4 gm mocharas powder was administered orally with milk twice daily and in both groups, local treatment in the form of sitz bath (abzan) with decoction of habbulaas 12 gm once daily was given for 8 weeks. Main outcome measure was improvement in Pelvic Organ Prolapse Quantification (POPQ) system, Pelvic Floor Distress Inventory Questionnaire (PFDIQ), Pelvic Floor Impact Questionnaire (PFIQ). Data were analyzed with student’s t-test, chi square test and fisher exact test.

Results: Significant improvement (P<0.001) was observed in total scores of PFDIQ and PFIQ within each group though the difference was non-significant on inter group comparison. No significant change in POPQ system was reported in both groups (P>0.05).